Alec Machiels, JD/MBA
Alec Machiels is a Partner at Pegasus Capital Advisors, L.P., a private equity fund manager. Mr. Machiels is a member of the firm’s Executive and Investment Commitees. He has over fifteen (15) years of private equity investing and investment banking experience. Previously, Mr. Machiels was a Financial Analyst in the Financial Services Group at Goldman Sachs International in London and in the Private Equity Group at Goldman Sachs and Co. in New York. Investments in which he has been highly involved in include Pure Biofuels, Molycorp Minerals, Traxys, Slipstream Communications, Coffeyville Resources and Merisant Company. He also co-founded and serves as a board member of Potentia Pharmaceuticals, Inc. and Apellis Pharmaceuticals, Inc., which respectively have drugs in development to treat macular degeneration and rare diseases and COPD. He also served as a member of the Board of Trustees of the American Federation of Arts where he chaired the endowment committee. Mr. Machiels is a graduate of Harvard Business School, KU Leuven Law School in Belgium and Konstanz University on Germany.